• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by AptarGroup Inc.

    5/9/25 4:12:00 PM ET
    $ATR
    Plastic Products
    Industrials
    Get the next $ATR alert in real time by email
    S-8 1 tm2513684d1_s8.htm FORM S-8

     

    As filed with the Securities and Exchange Commission on May 9, 2025

     

    Registration No. 333-

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM S-8

     

    REGISTRATION STATEMENT UNDER THE

    SECURITIES ACT OF 1933

     

    APTARGROUP, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   36-3853103
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    265 Exchange Drive, Suite 301, Crystal Lake, Illinois   60014
    (Address of Principal Executive Offices)   (Zip Code)

     

    AptarGroup, Inc. 2018 Equity Incentive Plan, as amended

    (Full title of the plan)

     

    Kimberly Chainey

    Executive Vice President, Chief Legal Officer and Corporate Secretary

    265 Exchange Drive, Suite 301

    Crystal Lake, Illinois 60014

    (Name and address of agent for service)

     

    (815) 477-0424

    (Telephone number, including area code, of agent for service)

     

    Copy to:

    Gary D. Gerstman

    Sidley Austin LLP

    One South Dearborn

    Chicago, Illinois 60603

    (312) 853-7000

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer x   Accelerated filer ¨
           
    Non-accelerated filer ¨   Smaller reporting company ¨
           
          Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    NOTE

     

    INFORMATION REQUIRED PURSUANT TO GENERAL INSTRUCTION E TO FORM S-8

     

    This Registration Statement on Form S-8 (this “Registration Statement”) is being filed by AptarGroup, Inc. (the “Company”), relating to 1,000,000 shares of its common stock, par value $0.01 per share (the “Common Stock”), issuable to eligible employees, non-employee directors, consultants, independent contractors and agents of the Company and its affiliates under the AptarGroup, Inc. 2018 Equity Incentive Plan, as amended (the “Plan”). This Registration Statement on Form S-8 hereby incorporates by reference the contents of the Company's prior Registration Statements on Form S-8 filed with the Securities and Exchange Commission (the “Commission”) on May 2, 2018 (Registration No. 333-224617), May 11, 2020 (Registration No. 333-238166) and May 4, 2023 (Registration No. 333-271658) relating to shares of Common Stock issuable to eligible employees, non-employee directors, consultants, independent contractors and agents of the Company and its affiliates under the Plan (collectively, the “Prior Registration Statements”). The Prior Registration Statements are currently effective. This Registration Statement relates to securities of the same class as those to which the Prior Registration Statements relate and is submitted in accordance with General Instruction E of Form S-8 regarding Registration of Additional Securities. Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statements are incorporated herein by reference and made part of this Registration Statement, except as amended hereby.

     

    PART II

     

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3. Incorporation of Certain Documents by Reference

     

    The following documents heretofore filed with the Commission by the Company are incorporated herein by reference:

     

    (a) The Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Commission on February 7, 2025.

     

    (b) The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Commission on May 2, 2025.

     

    (c) The Company’s Current Report on Form 8-K, filed with the Commission on May 8, 2025.

     

    (d) The description of the Common Stock, which is contained in the Registration Statement on Form 8-A filed with the Commission on April 5, 1993, including any subsequent amendment or any report filed for the purpose of updating such description, including Exhibit 4.17 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

     

    All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the respective dates of filing of such documents (such documents, and the documents enumerated above, being hereinafter referred to as “Incorporated Documents”). Any statement contained in an Incorporated Document shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed Incorporated Document modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

     

     

     

    Notwithstanding the foregoing, unless specifically stated to the contrary, none of the information disclosed by the Company under Items 2.02 or 7.01 of any Current Report on Form 8-K, including the related exhibits under Item 9.01, that the Company may from time to time furnish to the Commission will be incorporated by reference into, or otherwise included in, this Registration Statement.

     

    Item 8. Exhibits

     

    Exhibit
    Number
      Description of Exhibit 
    4.1   Amended and Restated Certificate of Incorporation of the Company, as amended, filed as Exhibit 4(a) to the Company’s Registration Statement on Form S-8 filed with the Commission on July 25, 2008, is hereby incorporated by reference.
         
    4.2   Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company, filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the Commission on May 2, 2024, is hereby incorporated by reference.
         
    4.3   Amended and Restated By-Laws of the Company, filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q, filed with the Commission on October 25, 2024, is hereby incorporated by reference.
         
    4.4   AptarGroup, Inc. 2018 Equity Incentive Plan, as amended effective May 7, 2025, filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Commission on May 8, 2025, is hereby incorporated by reference.
         
    *5.1   Opinion of Sidley Austin LLP.
         
    *23.1   Consent of Sidley Austin LLP (included in its opinion filed as Exhibit 5.1).
         
    *23.2   Consent of PricewaterhouseCoopers LLP.
         
    *24.1   Powers of Attorney (contained in the signature page to this Registration Statement)
         
    *107   Calculation of Filing Fee Table.

     

     

    * Filed herewith.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Crystal Lake, State of Illinois, on May 9, 2025.

     

      APTARGROUP, INC.
       
      By: /s/ Vanessa Kanu
        Vanessa Kanu
        Executive Vice President and Chief Financial Officer

     

    KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Stephan B. Tanda, Vanessa Kanu and Kimberly Chainey, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, in any and all capacities, to sign any or all amendments (including post-effective amendments) to this Registration Statement, including any filings under Rule 462 promulgated under the Securities Act, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated below.

     

     

     

     

    Signature Title Date
         
    /s/ Stephan B. Tanda President and Chief Executive Officer and May 9, 2025
    Stephan B. Tanda Director (Principal Executive Officer)  
         
    /s/ Vanessa Kanu Executive Vice President and May 9, 2025
    Vanessa Kanu Chief Financial Officer (Principal Financial Officer)  
         
    /s/ Daniel Ackerman Senior Vice President and Chief Accounting Officer (Principal Accounting Officer) May 9, 2025
    Daniel Ackerman
         
    /s/ Candace Matthews Chair of the Board and Director May 9, 2025
    Candace Matthews    
         
    /s/ George L. Fotiades Director May 9, 2025
    George L. Fotiades
         
    /s/ Sarah Glickman Director May 9, 2025
    Sarah Glickman    
         
    /s/ Giovanna Kampouri Monnas Director May 9, 2025
    Giovanna Kampouri Monnas    
         
    /s/ Isabel Marey-Semper Director May 9, 2025
    Isabel Marey-Semper
         
    /s/ B. Craig Owens Director May 9, 2025
    B. Craig Owens    
         
    /s/ Matthew Trerotola Director May 9, 2025
    Matthew Trerotola    
         
    /s/ Ralf K. Wunderlich Director May 9, 2025
    Ralf K. Wunderlich    
         
    /s/ Julie Xing Director May 9, 2025
    Julie Xing

     

     

     

    Get the next $ATR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATR

    DatePrice TargetRatingAnalyst
    9/4/2025$220.00Overweight
    KeyBanc Capital Markets
    1/7/2025$200.00Outperform
    Raymond James
    1/6/2025$173.00Buy → Neutral
    BofA Securities
    10/14/2024$155.00 → $215.00Hold → Buy
    Jefferies
    4/29/2024Mkt Perform → Outperform
    William Blair
    1/3/2024$125.00 → $150.00Neutral → Outperform
    Robert W. Baird
    1/20/2022$150.00 → $126.00Equal-Weight
    Morgan Stanley
    12/22/2021$162.00 → $156.00Overweight
    Wells Fargo
    More analyst ratings

    $ATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength

    Following an increase of almost 10% a year ago AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.48 per share, an almost 7% increase from the previous dividend amount, bringing the new annualized dividend to $1.92 per share. The payment date is November 13, 2025, to stockholders of record as of October 23, 2025. Stephan B. Tanda, Aptar President and CEO, commented, "Given the strength of our business outlook, the sustained long-term growth we anticipate from our Pharma segment, and our continued strong performance across all key financial metrics, the Board of Dir

    9/8/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Announces 2025 Investor Day

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Tuesday, September 9, 2025. The event will begin at 9:00 a.m. EDT. Presentations by members of executive management followed by a moderated Q&A session are expected to conclude at approximately 12:00 p.m. EDT. Additionally, for those participating in person, Aptar will host an innovation demonstration and group lunch with management. The general public can access the event and listen live by registering for the webcast. Attendees should plan to connect 15 minutes prior to the start of the event. Presentation slides will be posted on the

    9/4/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Reports Second Quarter 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following second quarter results for the period ended June 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731446602/en/Aptar Reports Second Quarter 2025 Results Second Quarter 2025 Highlights (compared to the prior year quarter) Reported sales increased 6% and core sales increased 3% Reported net income increased 24% to $112 million and adjusted EBITDA increased 13% from the prior year to $218 million Rep

    7/31/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets initiated coverage on AptarGroup with a new price target

    KeyBanc Capital Markets initiated coverage of AptarGroup with a rating of Overweight and set a new price target of $220.00

    9/4/25 8:59:59 AM ET
    $ATR
    Plastic Products
    Industrials

    Raymond James initiated coverage on AptarGroup with a new price target

    Raymond James initiated coverage of AptarGroup with a rating of Outperform and set a new price target of $200.00

    1/7/25 9:09:40 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup downgraded by BofA Securities with a new price target

    BofA Securities downgraded AptarGroup from Buy to Neutral and set a new price target of $173.00

    1/6/25 9:13:43 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Segment President Touya Gael sold $340,298 worth of shares (2,500 units at $136.12), decreasing direct ownership by 7% to 31,463 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    9/12/25 8:12:33 AM ET
    $ATR
    Plastic Products
    Industrials

    Chief Human Resources Officer Vinczeller Shiela sold $161,006 worth of shares (1,167 units at $137.97), decreasing direct ownership by 4% to 25,134 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    9/8/25 12:50:17 PM ET
    $ATR
    Plastic Products
    Industrials

    Segment President Prieur Marc sold $305,606 worth of shares (2,000 units at $152.80), decreasing direct ownership by 11% to 15,745 units (SEC Form 4)

    4 - APTARGROUP, INC. (0000896622) (Issuer)

    6/16/25 10:52:48 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    SEC Filings

    View All

    SEC Form 10-Q filed by AptarGroup Inc.

    10-Q - APTARGROUP, INC. (0000896622) (Filer)

    8/1/25 10:09:19 AM ET
    $ATR
    Plastic Products
    Industrials

    AptarGroup Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - APTARGROUP, INC. (0000896622) (Filer)

    7/31/25 5:06:50 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form 11-K filed by AptarGroup Inc.

    11-K - APTARGROUP, INC. (0000896622) (Filer)

    6/13/25 10:31:26 AM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Financials

    Live finance-specific insights

    View All

    Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength

    Following an increase of almost 10% a year ago AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.48 per share, an almost 7% increase from the previous dividend amount, bringing the new annualized dividend to $1.92 per share. The payment date is November 13, 2025, to stockholders of record as of October 23, 2025. Stephan B. Tanda, Aptar President and CEO, commented, "Given the strength of our business outlook, the sustained long-term growth we anticipate from our Pharma segment, and our continued strong performance across all key financial metrics, the Board of Dir

    9/8/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Reports Second Quarter 2025 Results

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported the following second quarter results for the period ended June 30, 2025, as compared to the corresponding period of the last fiscal year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250731446602/en/Aptar Reports Second Quarter 2025 Results Second Quarter 2025 Highlights (compared to the prior year quarter) Reported sales increased 6% and core sales increased 3% Reported net income increased 24% to $112 million and adjusted EBITDA increased 13% from the prior year to $218 million Rep

    7/31/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Declares Quarterly Dividend

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is August 14, 2025 to stockholders of record as of July 24, 2025. As previously announced, Aptar will hold a conference call on Friday, August 1, 2025 at 8:00 a.m. Central Time to discuss the Company's second quarter results for 2025. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com. Replay of the conference call can also be accessed for a limited time on the Investors page of the website. A

    7/10/25 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Leadership Updates

    Live Leadership Updates

    View All

    Aptar CFO, Robert (Bob) Kuhn, Has Decided to Step Down After 37 Years with the Company

    Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240725873916/en/(Left to right) Bob Kuhn, Executive Vice President and Chief Financial Officer since 2008, has decided to retire at the end of 2024; Vanessa Kanu will become Executive Vice President and CFO on January 1, 2025,

    7/25/24 5:20:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Global Finance and Operations Veteran Sarah Glickman to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230905451175/en/Sarah Glickman Joins Aptar's Board of Directors (Photo: Aptar) "We are pleased to welcome Sarah Glickman to our Board of Directors. Sarah's extensive knowledge of all aspects of corporate finance coupled with her global operational experience, including in the pharmaceutical industry

    9/5/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    Aptar Appoints Julie Xing to its Board of Directors

    AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230220005172/en/Julie Xing Joins Aptar's Board of Directors (Photo: Aptar) With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie's leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. With her solid track record of business transformation in multiple g

    3/1/23 5:00:00 PM ET
    $ATR
    Plastic Products
    Industrials

    $ATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/13/24 4:58:57 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 3:08:10 PM ET
    $ATR
    Plastic Products
    Industrials

    SEC Form SC 13G/A filed by AptarGroup Inc. (Amendment)

    SC 13G/A - APTARGROUP, INC. (0000896622) (Subject)

    2/12/24 11:53:37 AM ET
    $ATR
    Plastic Products
    Industrials